Prelude Capital Management, LLC Atossa Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
A detailed history of Prelude Capital Management, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 11,300 shares of ATOS stock, worth $13,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,300Holding current value
$13,108% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATOS
# of Institutions
70Shares Held
19.3MCall Options Held
95KPut Options Held
82.4K-
Vanguard Group Inc Valley Forge, PA5.75MShares$6.67 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.75MShares$3.19 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY2.23MShares$2.58 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.39MShares$1.61 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.21MShares$1.41 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $147M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...